Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Clinical trial NCT01463046 · COMPLETED
Trial details
- NCT number
- NCT01463046
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-11-14
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.